Logos Global Management LP Decreases Stake in Ventyx Biosciences, Inc. (NASDAQ:VTYX)

Logos Global Management LP lowered its holdings in Ventyx Biosciences, Inc. (NASDAQ:VTYX – Free Report) by 58.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 270,000 shares of the company’s stock after selling 387,016 shares during the quarter. Ventyx Biosciences accounts […]

Related Keywords

Ventyx Biosciences ,Ventyx Biosciences Inc ,Morgan Stanley ,Exchange Commission ,Credit Suisse Group ,Securities Exchange Commission ,Health Asset Management ,Nasdaq ,Nantahala Capital Management ,Virtu Financial ,Barclays Plc ,Logos Global Management ,Free Report ,Global Management ,Capital Management ,Director Somu Subramaniam ,Get Free Report ,Suisse Group ,Visit Holdingschannel ,Ventyx Biosciences Daily ,Nasdaq Vtyx ,Vtyx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,